Nexpoint Life Sciences
Dallas, TX · 3 funds and programs
Fund sponsor506(c)
Nexpoint Life Sciences of Dallas, TX is named on SEC Form D filings for 3 private funds and programs since 2021, most recently on Aug 11, 2026. Together they report $173M raised from 440 investor positions.
- Funds and programs
- 3Filed on Form D
- Total raised
- $173MCumulative sales reported on Form D, all funds
- Investor positions
- 440Summed across funds; one investor may be in several
- First fund
- Dec 2021Earliest first sale or filing
- Latest Form D
- Aug 11, 2026Most recent filing by any of its funds
- Latest fund's offering
- Rule 506(c)May advertise to verified accredited investors
Real estate funds (3)
Fund
First sale
Raised
Investors
Minimum
Offering
NexPoint Life Sciences III DST
Dallas, TXEmerging506(c)
First saleJan 2024
Raised$28.0M
Investors92
Minimum$100K
Offering506(c)
NexPoint Life Sciences II DST
Dallas, TXEmerging506(c)
First saleJun 2023
Raised$40.5M
Investors112
Minimum$100K
Offering506(c)
NexPoint Life Sciences DST
Dallas, TX
First saleDec 2021
Raised$105M
Investors236
Minimum$100K
Offering506(b)
Grouped by AltMountain from the company named on each Form D and the funds' names, so the list may be incomplete or include a related fund. New programs are added automatically when they file. Request a correction
From SEC filings, not verified. This page summarizes Form D filings as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the sponsor or its funds. “Raised” is cumulative sales, not current assets or performance. Full disclosures